You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《業績》諾和諾德(NVO.US)下調前景指引 股價盤前挫逾20%
阿思達克 07-29 20:46
丹麥藥業集團諾和諾德(Novo Nordisk A/S)下調2025年的銷售和營業利潤前景,銷售增長下調至介乎8%至14%之間,公司早在5月時預期銷售增長介乎13%至21%之間;營業利潤增長預期則從16%至24%下調至10%至16%。 公司稱,Wegovy在美國市場的增長預期將放緩,以及Ozempic在美國GLP-1糖尿病市場的增長亦同樣預期減緩,故下調盈利預測。 諾和諾德股價在歐洲股市中段下跌20%,報358.55丹麥克朗;其美股盤前亦下跌逾21%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account